Sicor Inc.
- Share via
The Irvine pharmaceutical company reported first-quarter earnings of $7.1 million, or 6 cents a share, compared with a loss of $165,000, or 2 cents a share, for the first quarter last year. Sales rose to $67.5 million from $53.6 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
